Clin2
NCT07661030Possibly a fitNot yet recruiting

Timing of gout medication to speed up flare recovery

Gout

Treatments studied

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests whether starting a new gout medicine called dotinurad at different times after a flare begins can help the flare go away faster. It may help people who have frequent gout attacks or certain health conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
142 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have been diagnosed with gout by a doctor.
  • You are having a gout flare that started within the last 7 days.
  • You have had at least 2 gout flares before, or you are under 40 with one flare, or you have high uric acid or other health issues like kidney problems or high blood pressure.
  • You have not taken certain gout or anti-inflammatory medicines recently (within the past month or two weeks).
  • You do not have severe kidney, liver, heart, or other major health problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07535034Recruiting· Phase 2
Testing Dotinurad for Gout in People Who Can't Take Other Medications

This trial tests a new drug called dotinurad for gout patients whose standard medications either don't work or cause side effects. Dotinurad works differently by helping your body get rid of uric acid (the substance that causes gout attacks), and the study will see if it safely lowers uric acid levels.

Birmingham, Alabama
NCT07089875Recruiting· Phase 3
Testing dotinurad vs allopurinol for people with gout

This study compares a new gout medicine called dotinurad to the common medicine allopurinol. It is for people who have had gout for at least a year, have had at least 2 gout attacks in the last year, and are already taking a stable dose of allopurinol but still have high uric acid levels.

Birmingham, Alabama
NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT07346079Recruiting· Phase 4
Corticotropin gel for acute gout flares

This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.

Boston, Massachusetts
NCT05658575Recruiting· Phase 2/Phase 3
Tablets to treat sudden gout flare pain

This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.

Birmingham, Alabama
NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy

This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.

Suwon, Gyeonggi-do

Hear when a new Gout trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.